| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 29,545 | 27,663 | 25,583 | | Cost of Revenue | 7,125 | 7,829 | 26,116 | | | Gross Profit | 22,420 | 19,833 | (533) | | | Operating Expenses | | Research Development | 6,643 | 5,977 | 6,214 | | Selling General and Administrative | 22,299 | 23,623 | 23,840 | | Non Recurring | 1,217 | 6,190 | 1,600 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,740) | (15,956) | (32,187) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,489 | 1,242 | 838 | | Earnings Before Interest And Taxes | (6,250) | (14,714) | (31,350) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (6,250) | (14,714) | (31,350) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,250) | (14,714) | (31,350) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (6,250) | (14,714) | (31,350) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,250) | ($14,714) | ($31,350) |
|
1.23% Nasdaq 
0.08 (5.41%) 
Income Statement
